Showing posts with label skin Cancer. Show all posts
Showing posts with label skin Cancer. Show all posts

Friday, December 4, 2015

Prevention and Control of Skin Cancer

Skin cancer is the most common cancer in the United States, and most cases are preventable . Persons with certain genetic risk factors, including having a lighter natural skin color; blue or green eyes; red or blonde hair; dysplastic nevi or a large number of common moles; and skin that burns, freckles, or reddens easily or becomes painful after time in the sun, have increased risk for skin cancer. Persons with a family or personal history of skin cancer, especially melanoma, are also at increased risk. Although these genetic factors contribute to individual risk, most skin cancers are also strongly associated with ultraviolet (UV) radiation exposure. Most UV exposure comes from the sun, although some persons use UV-emitting indoor tanning devices (e.g., beds, booths, and lamps).
The three most common types of skin cancer, in descending order, are basal cell carcinoma, squamous cell carcinoma, and melanoma. Basal cell carcinoma alone is thought to be more common than any other cancer, but central cancer registries* (CCRs) do not collect data on basal cell carcinoma, so incidence is unknown. Squamous cell carcinoma is less common than basal cell carcinoma and can cause death, although most cases are treatable. Melanoma is the least common of the three main types of skin cancer, but causes the most deaths. In 2012, CCRs in the United States reported approximately 67,000 new melanoma cases and 9,000 deaths from melanoma .
Overall, rates of melanoma incidence are approximately 60% higher among men than women (25.5 and 15.9 per 100,000, respectively, in 2012), and rates increase rapidly after age 50 years. However, among persons aged <50 years, melanoma is more common among women .
Rates of skin cancer have tripled since the early 1970s. Although much of the increase has been among early stage cancers, and mortality has remained relatively stable, more recent analyses have found increases among later stage cancers, and mortality rates for males have begun to increase.
Differences by race in skin cancer risk are largely related to differences in skin type and other genetic risk factors. The rate of melanoma in non-Hispanic whites (whites) is approximately 25 times higher than the rate in blacks and six times higher than the rate in Hispanics. However, a diagnosis of melanoma in blacks and Hispanics often occurs later than in whites, which has led to poorer survival rates.
The causal relationship between UV exposure and skin cancer among populations with comparatively more sun-sensitive skin is well established, and recent genetic research has found a UV exposure signature among mutations specific to melanoma . However, 37% of persons in the United States report getting sunburned each year, with the highest rate (65%) among white adults aged <30 years. Among persons reporting sunburn, 12% report four or more burns during the past year. Approximately 67% of men and 73% of women report using at least one method of sun protection when outdoors for >1 hour on a sunny day. However, use of each individual method of protection (e.g., sunscreen, hats, shade, and protective clothing) is substantially lower, especially among men. For example, only 21% of men and 41% of women report wearing sunscreen when outdoors for >1 hour on a sunny day. Although women tend to report higher rates of sun protection, intentional UV exposures, including sunbathing and indoor tanning, are more common among younger women than men . Only 10% of high school students report wearing sunscreen when outdoors for >1 hour on a sunny day . An estimated 11.6 million persons in the United States, including almost one in three white women aged 16–25 years, tan indoors each year (810). The U.S. Food and Drug Administration (FDA) recently reclassified tanning devices to better reflect their risk level, and requires that devices include warnings stating that their use is contraindicated for persons aged <18 years .
Evidence-Based Skin Cancer Prevention
Many skin cancers can be prevented by the strategies promulgated in the Surgeon General's Call to Action to Prevent Skin Cancer
Increase opportunities for sun protection in outdoor settings. Increasing shade and other opportunities for sun protection in outdoor recreational settings like parks, sports arenas, pools, beaches, and ski resorts can help reduce UV overexposure and support individual sun protection behaviors. Likewise, efforts to increase shade and provide support for other methods of sun protection in schools and occupational settings are important, especially for recess and other outdoor school activity areas and for outdoor work environments.
Provide individuals with the information they need to make informed, healthy choices about UV exposure. The general public often does not understand the widely available information on the UV Index.Effective messages with prompts on using sun protection when the UV Index is high might help increase use of sun protection at schools and in occupational settings. The U.S. Preventive Services Task Force recommends counseling children, adolescents, and young adults aged 10–24 years who have fair skin about minimizing their exposure to UV to reduce risk for skin cancer. Aligning sun protection messages with other physical activity and outdoor recreation messages, such as reminders to wear wide-brimmed hats when walking or to reapply sunscreen during water breaks, might provide an opportunity to address multiple important public health goals.
Promote policies that advance the national goal of preventing skin cancer. Policies at all levels, including federal, state, local, and institutional policies in workplaces, schools, and businesses, can help support skin cancer prevention. School policies that prohibit hats or student possession of sunscreen can create barriers to the use of these important sun protection methods. School and workplace policies that support sun protection include education on UV exposure, providing shade at school or work, and encouraging students and employees to use sun protection. Organizational or municipal shade policies can require the provision of shade when constructing or refurbishing public facilities or schools, thereby increasing the availability of shade.
Reduce harms from indoor tanning. UV from indoor tanning devices has been classified by the World Health Organization and the U.S. Department of Health and Human Services as a known human carcinogen. Federal, state, and local regulations have recently increased; 13 states, the District of Columbia, and several cities and counties have now banned the use of indoor tanning beds for persons aged <18 years ; however, tanning is particularly common among young adult white women and in areas near college campuses. The availability of tanning devices in less-regulated settings, such as homes, gyms, and apartment building common areas, can pose unique challenges for enforcing regulations.
Strengthen research, surveillance, monitoring, and evaluation related to skin cancer prevention. A better understanding of the role of UV exposure in skin cancer and evaluation of interventions to reduce overexposure to UV can help inform future prevention efforts. Although providers are required to report melanomas to CCRs, many in situ and early stage invasive melanomas are diagnosed and treated in outpatient settings, which often lack the reporting infrastructure found in hospital settings (1). Developing methods to better measure the prevalence of basal cell carcinoma and squamous cell carcinoma could also provide important information to measure the impact of public health efforts.
Implementation and Impact of Prevention Strategies
The Call to Action names various sectors as partners in prevention: policymakers; businesses and employers; health care systems, insurers, and clinicians; early learning centers, schools, colleges, and universities; community, nonprofit, and faith-based organizations; and persons and families. Some partners, such as the Arizona Department of Health Services and The University of Texas MD Anderson Cancer Center (MD Anderson), have implemented some of the prevention strategies named in the Call to Action through their previous and current work; other partners implemented these strategies after the release of the Call to Action.
The state of Arizona names sun safety as a top public health priority, and its previous and current work has addressed several of the Call to Action strategies. The SunWise program, developed by the U.S. Environmental Protection Agency and now supported by the National Environmental Education Foundation, is a health and environmental education program that teaches children how to protect themselves from overexposure to the sun. Beginning in 2005, Arizona state law has required that the SunWise program be incorporated as part of school education curricula for public school students in kindergarten through 8th grade (K–8). Recently, Arizona expanded the requirement to include state-licensed early learning center providers, and the requirement could be voluntarily adopted by private schools or by organizations such as sports teams and summer camps. Educators in Arizona's K–8 schools have access to school policy template language to make it easier to implement sun safety practices. Arizona officials are also working to improve melanoma reporting to the state's CCR.
A multidisciplinary team at MD Anderson is focusing on melanoma treatment and prevention through a program called the "Melanoma Moon Shot" that seeks to accelerate the pace that scientific discoveries are converted into clinical practices Studies of melanoma cancer genes are providing more information on the etiology and clinical behavior of melanoma, with the goal of increasing long-term survival rates and improving the antitumor immune response. Researchers are also investigating interventions to increase sun protective behaviors in children (e.g., Ray and the Sunbeatables: A Sun Safety Curriculum for Preschoolers), and to use appearance-focused interventions (e.g., highlighting UV-related skin damage) to impact tanning behaviors and attitudes in middle school students. MD Anderson served as an important resource for educating the Texas legislature on the risks of indoor tanning and sunscreen use in schools. In 2013, Texas passed legislation that prohibits the use of indoor tanning facilities by persons aged <18 years, and in June 2015, the state passed legislation that permits public school students to "possess and use a topical sunscreen product while on school property or at a school-related event or activity to avoid overexposure to the sun ... if the product is approved by the federal Food and Drug Administration for over-the-counter sunscreen products use" .
Cities have also been active in developing easy-to-implement sun-safe practices. The city of Miami Beach, Florida, has collaborated with Miami Beach's Mount Sinai Hospital to provide 50 free sunscreen dispensers on beaches and in parks. The city of Boston, Massachusetts, has provided 30 free sunscreen dispensers in citywide parks in collaboration with nonprofit organizations. A goal of the city of Montclair, New Jersey, is to become the "sun-smartest city in America" by working to implement all of the strategies outlined in the Call to Action. Other parks and recreation resources are available
Future Impact of Prevention Efforts
In the United States, an estimated total of $8.1 billion is spent annually on treatment for all skin cancers combined, and costs have been increasing in recent years. Without communitywide intervention programs, the annual cost of treating newly diagnosed melanoma cases is estimated to increase approximately 250% from 2011–2030 (from $457 million to $1.6 billion) However, comprehensive skin cancer prevention programs to reduce sun exposure, facilitate sun protection, prevent sunburn, and reduce indoor tanning can reduce future cases of skin cancer, and can be cost-effective. Prevention programs in Australia have been estimated to save AU$2.30 for every AU$1 invested. Implementation of communitywide programs in the United States has the potential to annually avert an estimated 230,000 melanoma cases and prevent $2.7 billion in costs for newly diagnosed melanomas.

Monday, October 19, 2015

Health News: Milk Recalled in California for Campylobacter Contamination ♦ Nanodiamonds might prevent tooth loss after root canals ♦ The end is in sight for reading glasses

Milk Recalled in California for Campylobacter Contamination Raw milk produced by Organic Pastures Dairy of Fresno County with a code date of OCT 24 is the subject of a statewide recall and quarantine order announced by California State Veterinarian Dr. Annette Jones. The quarantine order followed the confirmed detection of Campylobacter bacteria in raw whole milk. No illnesses have been reported at this time.
Researchers' cure of metastatic skin cancer revealed Metastatic Merkel-cell carcinoma is often fatal and there is no effective treatment. Now a researcher is reporting some positive results from treating this illness with a drug called idelalisib.
The end is in sight for reading glasses A researcher is developing a new eye lens, made from the same material found in smartphone and TV screens, which could restore long-sightedness in older people.
DNA sun protection UV radiation often damages our DNA. Researchers have now seen for the first time what happens in DNA building blocks when they are stimulated by ultraviolet light, and what they do to prevent themselves from being destroyed. The results show the molecules use the absorbed energy to set off a completely harmless reaction which prevents the genes being altered.

Nanodiamonds might prevent tooth loss after root canals Nanodiamonds may help patients that have had the dreaded root canal. Dental researchers have developed a nanodiamond-reinforced version of gutta percha, the compound that is used to fill void spaces in dental root canals to prevent infection that can lead to tooth loss. Tested in patient-extracted teeth, the nanodiamond-embedded polymer was substantially stronger than conventional gutta percha. In addition, the scientists tested gutta percha with nanodiamonds that had been loaded with antibiotics and found that the compound effectively prevented bacterial infection.

Tuesday, July 28, 2015

Cancer Research: New treatment options for a fatal leukemia ♦ 'Major player' in skin cancer genes identified ♦ Non-genetic cancer mechanism found

Prostate cancer: Why some tumors are resistant to radiotherapy  Scientists believe they have identified how some tiny regulatory molecules in cells can make prostate cancers resistant to radiotherapy. It is hoped that this new development could pave the way for more effective treatments -- allowing a lower dose of radiotherapy to be used while prolonging the lives of thousands of men.
Gene therapy may improve survival of patients with recurrent ovarian cancer Use of gene therapy to deliver a protein that suppresses the development of female reproductive organs may improve the survival of patients with ovarian cancer that has recurred after chemotherapy, which happens 70 percent of the time and is invariably fatal.
New treatment options for a fatal leukemia In industrialized countries, acute lymphoblastic leukemia is the most common form of cancer in children. An international research consortium has now succeeded in decoding a specific form of this leukemia, which is regarded as incurable, and in obtaining insights for new therapeutic possibilities.
'Major player' in skin cancer genes identified A subgroup of genetic mutations that are present in a significant number of melanoma skin cancer cases has been defined by a multidisciplinary team of researchers. Their findings shed light on an important mutation in this deadly disease, and may lead to more targeted anti-cancer therapies
Non-genetic cancer mechanism found Cancer can be caused solely by protein imbalances within cells, a study of ovarian cancer has found. The discovery is a major breakthrough because, until now, genetic aberrations have been seen as the main cause of almost all cancer.

Thursday, June 4, 2015

Deadly Melanoma rates have doubled

Melanoma rates doubled between 1982 and 2011 but comprehensive skin cancer prevention programs could prevent 20 percent of new cases between 2020 and 2030, according to this month’s Vital Signs report.
Skin cancer is the most common form of cancer in the U.S., and melanoma is the most deadly type of skin cancer. More than 90 percent of melanoma skin cancers are due to skin cell damage from ultraviolet (UV) radiation exposure. Melanoma rates increased from 11.2 per 100,000 in 1982 to 22.7 per 100,000 in 2011. The report notes that without additional community prevention efforts, melanoma will continue to increase over the next 15 years, with 112,000 new cases projected in 2030. The annual cost of treating new melanoma cases is projected to nearly triple from $457 million in 2011 to $1.6 billion in 2030.
This Vital Signs report shows that melanoma is responsible for more than 9,000 skin cancer deaths each year. In 2011, more than 65,000 melanoma skin cancers were diagnosed. By 2030, according to the report, effective community skin cancer prevention programs could prevent an estimated 230,000 melanoma skin cancers and save $2.7 billion dollars in treatment costs. Successful programs feature community efforts that combine education, mass media campaigns, and policy changes to increase skin protection for children and adults.
“Melanoma is the deadliest form of skin cancer, and it’s on the rise,” said CDC Director Tom Frieden, M.D., M.P.H. “Protect yourself from the sun by wearing a hat and clothes that cover your skin. Find some shade if you’re outside, especially in the middle of the day when the dangerous rays from the sun are most intense, and apply broad-spectrum sunscreen.”
Researchers reviewed data from CDC’s National Program of Cancer Registries and the National Cancer Institute’s Surveillance, Epidemiology and End Results Program (SEER) to help determine the increase in melanoma rates.
“The rate of people getting melanoma continues to increase every year compared to the rates of most other cancers, which are declining,” said Lisa Richardson, MD, MPH, Director of the Division of Cancer Prevention and Control. “If we take action now, we can prevent hundreds of thousands of new cases of skin cancers, including melanoma, and save billions of dollars in medical costs.”
This Vital Signs report highlights the recommendations for communities from the Community Guide for Preventive Services. Communities can increase shade on playgrounds, at public pools, and other public spaces, promote sun protection in recreational areas, encourage employers, childcare centers, schools, and colleges to educate about sun safety and skin protection, and restrict the availability and use of indoor tanning by minors.  Everyone is encouraged to protect their skin with protective clothing, wide-brimmed hats, broad-spectrum SPF sunscreen, and seek shade outdoors.
Through the Affordable Care Act, more Americans will qualify to get healthcare coverage that fits their needs and budget, including important preventive services. Behavioral counseling is now provided with no cost-sharing to counsel people aged 10–24 years with fair skin about limiting their exposure to UV radiation to reduce risk of skin cancer. Visit Healthcare.gov or call 1-800-318-2596 (TTY/TDD 1-855-889-4325) to learn more.
To learn about CDC’s efforts to prevent skin cancer, visit: www.cdc.gov/cancer/skin.
Vital Signs is a report that appears on the first Tuesday of the month as part of the CDC journal Morbidity and Mortality Weekly Report. The report provides the latest data and information on key health indicators. These are cancer prevention, obesity, tobacco use, motor vehicle passenger safety, prescription drug overdose, HIV/AIDS, alcohol use, health care-associated infections, cardiovascular health, teen pregnancy, and food safety.
Melanoma rates doubled between 1982 and 2011 but comprehensive skin cancer prevention programs could prevent 20 percent of new cases between 2020 and 2030, according to this month’s Vital Signs report.
Skin cancer is the most common form of cancer in the U.S., and melanoma is the most deadly type of skin cancer. More than 90 percent of melanoma skin cancers are due to skin cell damage from ultraviolet (UV) radiation exposure. Melanoma rates increased from 11.2 per 100,000 in 1982 to 22.7 per 100,000 in 2011. The report notes that without additional community prevention efforts, melanoma will continue to increase over the next 15 years, with 112,000 new cases projected in 2030. The annual cost of treating new melanoma cases is projected to nearly triple from $457 million in 2011 to $1.6 billion in 2030.
This Vital Signs report shows that melanoma is responsible for more than 9,000 skin cancer deaths each year. In 2011, more than 65,000 melanoma skin cancers were diagnosed. By 2030, according to the report, effective community skin cancer prevention programs could prevent an estimated 230,000 melanoma skin cancers and save $2.7 billion dollars in treatment costs. Successful programs feature community efforts that combine education, mass media campaigns, and policy changes to increase skin protection for children and adults.
“Melanoma is the deadliest form of skin cancer, and it’s on the rise,” said CDC Director Tom Frieden, M.D., M.P.H. “Protect yourself from the sun by wearing a hat and clothes that cover your skin. Find some shade if you’re outside, especially in the middle of the day when the dangerous rays from the sun are most intense, and apply broad-spectrum sunscreen.”
Researchers reviewed data from CDC’s National Program of Cancer Registries and the National Cancer Institute’s Surveillance, Epidemiology and End Results Program (SEER) to help determine the increase in melanoma rates.
“The rate of people getting melanoma continues to increase every year compared to the rates of most other cancers, which are declining,” said Lisa Richardson, MD, MPH, Director of the Division of Cancer Prevention and Control. “If we take action now, we can prevent hundreds of thousands of new cases of skin cancers, including melanoma, and save billions of dollars in medical costs.”
This Vital Signs report highlights the recommendations for communities from the Community Guide for Preventive Services. Communities can increase shade on playgrounds, at public pools, and other public spaces, promote sun protection in recreational areas, encourage employers, childcare centers, schools, and colleges to educate about sun safety and skin protection, and restrict the availability and use of indoor tanning by minors.  Everyone is encouraged to protect their skin with protective clothing, wide-brimmed hats, broad-spectrum SPF sunscreen, and seek shade outdoors.
Through the Affordable Care Act, more Americans will qualify to get healthcare coverage that fits their needs and budget, including important preventive services. Behavioral counseling is now provided with no cost-sharing to counsel people aged 10–24 years with fair skin about limiting their exposure to UV radiation to reduce risk of skin cancer. Visit Healthcare.gov or call 1-800-318-2596 (TTY/TDD 1-855-889-4325) to learn more.
To learn about CDC’s efforts to prevent skin cancer, visit: www.cdc.gov/cancer/skin.
Vital Signs is a report that appears on the first Tuesday of the month as part of the CDC journal Morbidity and Mortality Weekly Report. The report provides the latest data and information on key health indicators. These are cancer prevention, obesity, tobacco use, motor vehicle passenger safety, prescription drug overdose, HIV/AIDS, alcohol use, health care-associated infections, cardiovascular health, teen pregnancy, and food safety.


Thursday, December 18, 2014

12/18/14 Health News: E. COLI VICTIM SUE WHOLE FOODS ♦ Trichinellosis outbreak in Belgium ♦ New treatment for drug-resistant skin cancer

PARENTS OF E. COLI VICTIM SUE WHOLE FOODS
The parents of Joshua Kaye are suing Whole Foods Market over their son’s death. Eight-year-old Joshua from Braintree, MA, died last summer from an E. coli 0157:H7 infection that turned into hemolytic uremic syndrome (HUS). Multiple people were sickened and epidemiological evidence traced the source to grass-fed ground beef back to Whole Foods. “Federal agents were... Continue Reading
 Trichinellosis outbreak reported in Belgium   
Health officials in Belgium have reported that at least 14 people have been infected with the parasitic nematode worm Trichinella After eating wild boar meat at three different restaurants in early November  Continue Reading
SPENDING BILL BANS ‘CHINESE CHICKEN’ FROM FEDERAL MEAL PROGRAMS
A provision included in the $1.1-trillion spending bill Congress passed last week and which is now headed to the president’s desk prevents poultry processed in China from being used in the National School Lunch Program, School Breakfast Program, Child and Adult Care Food Program and Summer Food Service Program (Section 736 of Division A). Four Chinese poultry-processing plants have... Continue Reading
New targeted drugs could treat drug-resistant skin cancer
A brand new family of cancer drugs designed to block several key cancer-causing proteins at once could potentially treat incurable skin cancers, a major new study reports. Clinical trials to test the new drugs in patients should begin as early as 2015 Continue Reading

Tuesday, December 16, 2014

12/16/14 Health News: CHINESE CHICKEN’ BANNED ♦ New drugs for drug-resistant skin cancer ♦ Discovery explains why we gain weight ♦ Energy efficient homes linked to asthma

SPENDING BILL BANS ‘CHINESE CHICKEN’ FROM FEDERAL MEAL PROGRAMS
A provision included in the $1.1-trillion spending bill Congress passed last week and which is now headed to the president’s desk prevents poultry processed in China from being used in the National School Lunch Program, School Breakfast Program, Child and Adult Care Food Program and Summer Food Service Program (Section 736 of Division A). Four Chinese poultry-processing plants have... Continue Reading
New targeted drugs could treat drug-resistant skin cancer
A brand new family of cancer drugs designed to block several key cancer-causing proteins at once could potentially treat incurable skin cancers, a major new study reports. Clinical trials to test the new drugs in patients should begin as early as 2015 Continue Reading
Decoding fat cells: Discovery may explain why we gain weight
Researchers believe they're on track to solve the mystery of weight gain -- and it has nothing to do with indulging in holiday eggnog. They discovered that a protein, Thy1, has a fundamental role in controlling whether a primitive cell decides to become a fat cell, making Thy1 a possible therapeutic target, according to a study Continue Reading
Energy efficient homes linked to asthma

The drive for energy efficient homes could increase asthma risks, according to new research that has found that a failure by residents to heat and ventilate retrofitted properties could lead to more people developing the respiratory condition Continue Reading

Tuesday, June 3, 2014

6/3/14 Gut Bacteria Help Make Us Fat and Thin ♦ Skin Cancer Trial Results 'Exciting' ♦ Restaurants Gambled with Diners’ Health ♦ Foodborne illness places heaviest burden on youngest kids

Skin Cancer Trial Results 'Exciting'
The results of two international trials against advanced skin cancer have been hailed as "exciting and striking". Both treatments, for advanced melanoma, are designed to enable the immune system to recognise and target tumours. Continue Reading

Foodborne illness places heaviest burden on youngest kids

With the incidence of 9 major foodborne diseases not changing significantly since 2006-2008, according to a new preliminary report for 2013, the Centers for Disease Control and Prevention (CDC) says more needs to be done for prevention.
For 7 of the diseases the incidence was highest among children aged younger than 5 years. Those pathogens were: Campylobacter; Cryptosporidium; Salmonella; Shiga toxin-producing Escherichia coli (STEC) O157 and non-O157; Shigella; and Yersinia. Continue Reading
Food safety storm — restaurants gambled with diners’ health
ALMOST 40 eastern suburbs restaurants and cafes tried to sell food which might have gone off after a severe storm cut power for up to two days. In a report to the Eastern Health Authority’s May meeting, acting senior environmental health officer Nadia Conci says inspectors visited 55 premises in the wake of the February 4 storm. Ms Conci said many of the businesses failed to throw out food that could have been contaminated after being unrefrigerated for up to 48 hours.Continue Reading

How Gut Bacteria Help Make Us Fat and Thin

For the 35 percent of American adults who do daily battle with obesity, the main causes of their condition are all too familiar: an unhealthy diet, a sedentary lifestyle and perhaps some unlucky genes. In recent years, however, researchers have become increasingly convinced that important hidden players literally lurk in human bowels: billions on billions of gut microbes. Fortunately, researchers are beginning to understand the differences between the wrong mix and a healthy one Continue Reading

Friday, May 23, 2014

Skin Cancer Patients Have More Treatment Options

Science is discovering new ways to attack cancer cells on different fronts. Since 2011, the Food and Drug Administration (FDA) has approved five drug treatments for melanoma and other skin cancers, giving patients more options to meet their specific needs. Today, patients have better treatments, better outcomes and a longer life.
May is Skin Cancer Awareness Month and a good time to raise awareness about innovations in cancer treatment.
Skin Cancer Rates Are Rising
There are three main types of skin cancer: basal cell carcinoma, squamous cell carcinoma and melanoma. Although less common, melanoma is the most aggressive and dangerous.
In the United States, skin cancer rates are rising. The National Cancer Institute estimates that in 2014, there will be:
  • 76,100 new cases of melanoma and 9,710 deaths.
  • 2 million new cases of nonmelanoma skin cancer, with fewer than 1,000 deaths.
Cancer begins in the cells. When normal cells grow old or damaged, they usually die, and new cells replace them. With cancer, new cells grow when they’re not needed, and old or damaged cells don’t die when they should—forming a mass of tissue (a growth or tumor). Skin cancer can invade normal tissue and spread throughout the body.
Treatments to remove or destroy the disease completely depend on the type and stage of cancer. Before 2011, only five drugs were approved by FDA for treating melanoma.
Most were standard chemotherapy drugs that shrank the tumors but were effective in less than 15% of patients, says Patricia Keegan, M.D., an oncologist with FDA. “Most people who took those drugs didn’t get much benefit from them,” she adds.
Since 2011, FDA has approved two melanoma drugs and one treatment combination – Zelboraf (vemurafenib), Tafinlar (dabrafenib), and Mekinist (trametinib) in combination with Tafinlar—that in clinical studies shrank tumors in about half the patients. For Zelboraf and another new melanoma drug, Yervoy (ipilimumab), patients using the drugs lived longer than if they received traditional chemotherapy, Keegan says.
New Hope for Melanoma Patients
Yervoy is a new class of immune therapy approved for treatment of patients with melanoma that cannot be removed with surgery and is not limited to melanoma with certain gene mutations. It blocks the molecule cytotoxic T-lymphocyte antigen (CTLA-4) and helps the body’s immune system to recognize, target and attack cells in melanoma tumors. Scientists have been trying to harness this ability for more than 100 years, Keegan says.
“We’ve had a lot of experience with tumor vaccines, hoping the patient’s body will attack the cancer as it would foreign bacteria. But most have been unsuccessful until now,” Keegan says.
Yervoy doesn’t actually attack the tumors. Instead, it helps the body’s white blood cells recognize tumor cells as foreign and reject them.
Zelboraf, Tafinlar and Mekinist are personalized medicines (health care customized at the molecular level) used to treat patients with melanoma whose tumors have the BRAF V600E gene mutation. They keep tumors from growing by blocking the mutated BRAF gene.
What’s driving these advancements?
“The science is targeting driver mutations—abnormal genes of cancer cells that make tumors grow uncontrollably—and designing drugs that block them,” Keegan says. “It’s not always effective because tumors often find a back door when you shut down one path. So scientists are working on multiple therapies that work together to block various pathways.”
Combating cancer growth is like building a dam to control water flowing down a hill, Keegan says. The water (or cancer) will find another path. “That’s why we need several controls working together to prevent cells from multiplying and spreading,” she explains. “If you block only one path, the cancer might find a side route.”
That’s the case with a combination drug therapy approved by FDA in January 2014. Mekinist and Tafinlar jointly treat patients with advanced melanoma that is metastatic (late stage) or can’t be surgically removed. These drugs block signaling in different sites of the same molecular pathway promoting cancer cell growth.
Another Breakthrough
FDA has also approved the first drug for treating metastic basal cell carcinoma: Erivedge (vismodegib). For a small fraction of the population, this cancer is very serious. Doctors often can’t cut out certain tumors—maybe because they’re on the face, head, nose or eyelid—and patients end up with disfiguring lesions. People with Gorlin syndrome—a rare form of skin cancer that can involve many parts of the body—are especially vulnerable because their cancer often returns or spreads.
Erivedge could give these patients options they never had before by shrinking their tumors and allowing them to control their lesions for months at a time, Keegan says.
“As oncologists, we’re still learning the best way to use Erivedge to control these really difficult lesions,” Keegan says. “The drug is effective for 30% to 40% of patients, but for them it’s a breakthrough because they have run out of options.”

Wednesday, April 2, 2014

Skin Cancer The Burning Truth


Burning Truth logo
A lot of people believe indoor tanning is safe. The truth is, tanning beds injure thousands of people each year badly enough to go to a hospital, and that's just the beginning. People who indoor tan damage their skin, often getting wrinkles, warts, rashes, and dark spots. They may even get skin infections, cataracts in their eyes, and—most dangerous of all—skin cancer, including deadly melanoma.
Skin cancer is the most common cancer in the United States, and unlike almost all other kinds of cancer, the rates are climbing. This is definitely not a trend you want to follow. Avoiding indoor tanning and protecting yourself from the sun when outdoors are the best ways to reduce your chance of getting skin cancer.
CDC's new Burning Truth communication initiative encourages you to keep your skin healthy and beautiful for life by protecting yourself from too much exposure to ultraviolet (UV) rays from the sun and tanning beds.
Know the Burning Truth about these tanning myths—
A Base Tan Is Not a Safe Tan. There is a common misconception that a tan acts as the body's natural protection against sunburn. The Burning Truth: A tan is the body's response to injury from UV rays, showing that damage has been done. A "base tan" only provides a sun protection factor (SPF) of about 3 or less, which does little to protect you from future UV exposure.
Tanned Skin Is Not Healthy Skin. Some people believe the tanning bed gives them a "healthy glow." The Burning Truth: Whether tanning or burning, you are exposing yourself to harmful UV rays that damage your skin. In fact, every time you tan, you increase your risk of melanoma. The truly healthy glow is your natural skin color.
Controlled Tanning Is Not Safe Tanning. You may have heard that indoor tanning is the safer way to tan because you can control your level of exposure to UV rays. The Burning Truth: Sensible indoor tanning is a myth. Indoor tanning exposes you to intense UV rays, increasing your risk of melanoma—the second most common cancer in women between 20 and 29 years old.
Resources
Help spread The Burning Truth by sharing this information with your friends and family! Click on the posters below to find printable posters and buttons to share on all your favorite social networks.